Targeting the ERK signaling pathway in cancer therapy, Annals of Medicine, vol.14, issue.3 ,
DOI : 10.1016/j.gde.2003.12.002
URL : https://hal.archives-ouvertes.fr/hal-00321058
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer, Oncogene, vol.24, issue.22, pp.3291-3310, 2007. ,
DOI : 10.1038/72799
Targeted therapy in cancer, Cancer Chemotherapy and Pharmacology, vol.20, issue.18, pp.1113-1132, 2015. ,
DOI : 10.1158/1078-0432.CCR-14-0603
In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer, Anticancer Res, vol.35, pp.175-182, 2015. ,
Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia, Leukemia, vol.dii:pii, issue.9, pp.1803-1812, 2013. ,
DOI : 10.1038/leu.2011.234
Th??rapeutiques cibl??es dans??les??leuc??mies aigu??s, R??animation, vol.15, issue.4, pp.278-284, 2006. ,
DOI : 10.1016/j.reaurg.2006.06.002
Le traitement des leuc??mies aigu??s ?? promy??locytes par l'acide tout-trans r??tino??que., m??decine/sciences, vol.7, issue.5, p.460, 1991. ,
DOI : 10.4267/10608/4386
Mechanisms of action of therapeutic antibodies for cancer, Molecular Immunology, vol.67, issue.2, pp.28-45, 2015. ,
DOI : 10.1016/j.molimm.2015.04.002
Anticorps monoclonal anti-CD20 (rituximab) dans??les??maladies h??matologiques et??les??affections auto-immunes, R??animation, vol.15, issue.4, pp.270-277, 2006. ,
DOI : 10.1016/j.reaurg.2006.06.015
Tumor microenvironment: Sanctuary of the devil, Cancer Letters, vol.368, issue.1, pp.7-13, 2015. ,
DOI : 10.1016/j.canlet.2015.07.039
Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death, International Journal of Molecular Sciences, vol.9, issue.3, pp.9545-9571, 2012. ,
DOI : 10.1016/j.ccr.2012.02.022
Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition, Cancer and Metastasis Reviews, vol.13, issue.2, pp.17-39, 2014. ,
DOI : 10.1586/era.12.165
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer, Proceedings of the National Academy of Sciences, vol.17, issue.2, pp.3360-3365, 2007. ,
DOI : 10.1093/intimm/dxh194
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer, Proceedings of the National Academy of Sciences, vol.34, issue.2, pp.18538-18543, 2005. ,
DOI : 10.1002/eji.200324181
A phase II study of catumaxomab administered intra- and postoperatively as part of a multimodal approach in primarily resectable gastric cancer, Gastric Cancer, vol.29, pp.833-842, 2015. ,
DOI : 10.1200/JCO.2010.34.3939
Blinatumomab: a CD19/CD3 bispecific T cell engager (BiTE) with unique anti-tumor efficacy, Leukemia & Lymphoma, vol.124, issue.5, pp.1021-1032, 2016. ,
DOI : 10.1093/intimm/dxu089
Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia, Journal of Hematology & Oncology, vol.124, issue.21, p.104, 2015. ,
DOI : 10.1126/scitranslmed.3005930
URL : http://doi.org/10.1186/s13045-015-0195-4
Macrophage regulation of tumor responses to anticancer therapies, Cancer Cell, vol.23, pp.277-286, 2013. ,
Opinion: Tumour-educated macrophages promote tumour progression and metastasis, Nature Reviews Cancer, vol.4, issue.1, pp.71-78, 2004. ,
DOI : 10.1038/nrc1256
Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages, Cancer Letters, vol.326, issue.1, pp.59-68, 2012. ,
DOI : 10.1016/j.canlet.2012.07.020
The role of tumor-associated macrophages in tumor vascularization, Vascular Cell, vol.5, issue.1, p.20, 2013. ,
DOI : 10.1186/2045-824X-5-20
Alternative activation of macrophages, Nature Reviews Immunology, vol.3, issue.1, pp.23-35, 2003. ,
DOI : 10.1038/nri978
URL : https://hal.archives-ouvertes.fr/hal-00474829
Role of Macrophage Polarization in Tumor Angiogenesis and Vessel Normalization, Int. Rev. Cell Mol. Biol, vol.301, pp.1-35, 2013. ,
DOI : 10.1016/B978-0-12-407704-1.00001-4
Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells, Blood, vol.110, issue.13, pp.4319-4330, 2007. ,
DOI : 10.1182/blood-2007-02-072587
MUC1: a multifaceted oncoprotein with a key role in cancer progression, Trends in Molecular Medicine, vol.20, issue.6, pp.332-342, 2014. ,
DOI : 10.1016/j.molmed.2014.02.007
TG4010: a vaccine with a therapeutic role in cancer, Immunotherapy, vol.8, issue.5, pp.511-519, 2016. ,
DOI : 10.2217/imt-2016-0015
Mechanism of action of lenalidomide in hematological malignancies, Journal of Hematology & Oncology, vol.2, issue.1 ,
DOI : 10.1186/1756-8722-2-36
Thalidomide: mechanisms of action and new insights in hematology ,
Pomalidomide for multiple myeloma, Expert Review of Hematology, vol.7, issue.6, pp.613-618, 2015. ,
DOI : 10.1586/17474086.2014.966074
URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.653.6228
Lymphatic vessels and cancer, Med. Sci. MS, vol.21, pp.839-847, 2005. ,
Targeting hypoxia in cancer therapy, Nature Reviews Cancer, vol.13, issue.6, pp.393-410, 2011. ,
DOI : 10.1158/1078-0432.CCR-06-2126
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy, Science, vol.307, issue.5706, pp.58-62, 2005. ,
DOI : 10.1126/science.1104819
Numerical modeling of drug delivery in a dynamic solid tumor microvasculature, Microvascular Research, vol.99, pp.43-56, 2015. ,
DOI : 10.1016/j.mvr.2015.02.007
Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.7, pp.790-797, 2008. ,
DOI : 10.2174/187152008785914798
Multidrug resistance in brain tumors: roles of the blood-brain barrier, Cancer and Metastasis Reviews, vol.20, issue.1/2, pp.13-25, 2001. ,
DOI : 10.1023/A:1013104423154
Pharmacogenetics and pharmacogenomics of anticancer agents, CA: A Cancer Journal for Clinicians, vol.59, issue.1, pp.42-55, 2009. ,
DOI : 10.3322/caac.20002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109906
Pharmacogenomics of Sex Difference in Chemotherapeutic Toxicity, Current Drug Discovery Technologies, vol.4, issue.1, pp.59-68, 2007. ,
DOI : 10.2174/157016307781115485
Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics, Chronobiology International, vol.86, issue.1, pp.177-189, 2002. ,
DOI : 10.1093/jnci/86.21.1608
Molecular mechanisms of cisplatin resistance, Oncogene, vol.12, issue.15, pp.1869-1883, 2012. ,
DOI : 10.1038/35060032
Pharmacokinetics and individual dose adjustment of carboplatin], Spec No, pp.17-23, 2000. ,
Cancer drug resistance: an evolving paradigm, Nature Reviews Cancer, vol.14, issue.10, pp.714-726, 2013. ,
DOI : 10.1093/neuonc/nos158
The role of ??III tubulin in predicting chemoresistance in non-small cell lung cancer, Lung Cancer, vol.67, issue.2, pp.136-143, 2010. ,
DOI : 10.1016/j.lungcan.2009.09.007
Mesenchymal Stromal Cells: New Directions, Cell Stem Cell, vol.10, issue.6, pp.709-716, 2012. ,
DOI : 10.1016/j.stem.2012.05.015
URL : http://doi.org/10.1016/j.stem.2012.06.004
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement, Cytotherapy, vol.8, issue.4, pp.315-317, 2006. ,
DOI : 10.1080/14653240600855905
Sources of Adult Mesenchymal Stem Cells and their Applicability for Musculoskeletal Applications, Current Stem Cell Research & Therapy, vol.7, issue.2, pp.103-109, 2012. ,
DOI : 10.2174/157488812799219027
Concise Review: Multipotent Mesenchymal Stromal Cells in Blood, STEM CELLS, vol.86, issue.(suppl), pp.69-77, 2007. ,
DOI : 10.1091/mbc.E02-02-0105
Chondrogenesis of mesenchymal stem cells: role of tissue source and inducing factors, Stem Cell Research & Therapy, vol.1, issue.4, p.31, 2010. ,
DOI : 10.1186/scrt31
Mesenchymal stem cells: Molecular characteristics and clinical applications, World J. Stem Cells, vol.2, pp.67-80, 2010. ,
In??vivo real-time visualization of mesenchymal stem cells tropism for cutaneous regeneration using NIR-II fluorescence imaging, Biomaterials, vol.53, pp.265-273, 2015. ,
DOI : 10.1016/j.biomaterials.2015.02.090
Multilineage Potential of Adult Human Mesenchymal Stem Cells, Science, vol.284, issue.5411, pp.143-147, 1999. ,
DOI : 10.1126/science.284.5411.143
Pluripotency of mesenchymal stem cells derived from adult marrow, Nature, vol.92, issue.6893, pp.41-49, 2002. ,
DOI : 10.1038/72753
Mesenchymal stem cells: Paracrine signaling and differentiation during cutaneous wound repair, Experimental Cell Research, vol.316, issue.14, pp.2213-2219, 2010. ,
DOI : 10.1016/j.yexcr.2010.05.009
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902653
Paracrine effects of stem cells in wound healing and cancer progression (Review), International Journal of Oncology, vol.44, pp.1789-1798, 2014. ,
DOI : 10.3892/ijo.2014.2385
Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing, Stem Cell Research & Therapy, vol.56, issue.1, p.90, 2015. ,
DOI : 10.1124/pr.56.4.3
URL : https://hal.archives-ouvertes.fr/pasteur-01164725
Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms, Respiratory Research, vol.14, issue.1, p.9, 2013. ,
DOI : 10.1186/1465-9921-14-9
URL : http://doi.org/10.1186/1465-9921-14-9
Role of mesenchymal cells in the natural history of ovarian cancer: a review, Journal of Translational Medicine, vol.36, issue.9737, p.271, 2014. ,
DOI : 10.1016/j.ejso.2010.04.005
URL : https://hal.archives-ouvertes.fr/inserm-01202727
Mechanisms of action of mesenchymal stem cells in cutaneous wound repair and regeneration, Cell and Tissue Research, vol.10, issue.3, pp.371-377, 2012. ,
DOI : 10.1517/14712590903456011
Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing, PLoS ONE, vol.100, issue.4704, p.1886, 2008. ,
DOI : 10.1371/journal.pone.0001886.t003
Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses, International Journal of Cancer, vol.13, pp.2143-2152, 2010. ,
DOI : 10.4049/jimmunol.168.2.689
A regulatory cross-talk between V??9V??2 T lymphocytes and mesenchymal stem cells, European Journal of Immunology, vol.168, issue.3, pp.752-762, 2009. ,
DOI : 10.4049/jimmunol.168.12.6336
In vitro and in vivo neurogenic potential of mesenchymal stem cells isolated from different sources, Journal of Biosciences, vol.30, issue.1, pp.157-169, 2014. ,
DOI : 10.1016/j.ijdevneu.2012.05.006
Mesenchymal stem cells for the treatment of neurodegenerative disease, Regenerative Medicine, vol.5, issue.6, pp.933-946, 2010. ,
DOI : 10.2217/rme.10.72
Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?, Cellular and Molecular Life Sciences, vol.7, issue.4, pp.3871-3882, 2013. ,
DOI : 10.1016/j.stem.2010.09.009
Therapeutic applications of mesenchymal stem cells for amyotrophic lateral sclerosis, Stem Cell Research & Therapy, vol.5, issue.2, p.32, 2014. ,
DOI : 10.1186/scrt421
Potential for neural differentiation of mesenchymal stem cells Adv ,
Bone-marrow-derived mesenchymal stem cell therapy for neurodegenerative diseases, Expert Opinion on Biological Therapy, vol.65, issue.12, pp.1487-1497, 2009. ,
DOI : 10.1517/14712590903186956
Wharton's jelly derived mesenchymal stromal cells: Biological properties, induction of neuronal phenotype and current applications in neurodegeneration research, Acta Histochemica, vol.117, issue.4-5, pp.329-338, 2015. ,
DOI : 10.1016/j.acthis.2015.02.005
Engineering mesenchymal stem cells for regenerative medicine and drug delivery, Methods, vol.84, pp.3-16, 2015. ,
DOI : 10.1016/j.ymeth.2015.03.002
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526354
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine, Experimental & Molecular Medicine, vol.154, issue.11, p.54, 2013. ,
DOI : 10.3324/haematol.11869
URL : http://www.nature.com/emm/journal/v45/n11/pdf/emm201394a.pdf
Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells, Gene Therapy, vol.285, issue.10, pp.730-738, 2008. ,
DOI : 10.1634/stemcells.2004-0176
Contributions of the Host Microenvironment to Cancer-Induced Bone Disease, Cancer Research, vol.74, issue.6, pp.1625-1631, 2014. ,
DOI : 10.1158/0008-5472.CAN-13-2645
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche, Nature, vol.174, issue.7069, pp.820-827, 2005. ,
DOI : 10.4049/jimmunol.174.6.3686
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945882
Tumor microenvironment and the role of mesenchymal stromal cells, Neoplasma, vol.60, issue.01, pp.1-10, 2013. ,
DOI : 10.4149/neo_2013_001
Tumor microenvironment: Bone marrow-mesenchymal stem cells as key players, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1836, issue.2, pp.321-335, 2013. ,
DOI : 10.1016/j.bbcan.2013.10.004
Direct Evidence of Mesenchymal Stem Cell Tropism for Tumor and Wounding Microenvironments Using In Vivo Bioluminescent Imaging, Stem Cells, vol.116, issue.10, pp.2614-2623, 2009. ,
DOI : 10.1056/NEJM198612253152606
IL1?? Induces Mesenchymal Stem Cells Migration and Leucocyte Chemotaxis Through NF-??B, Stem Cell Reviews and Reports, vol.9, issue.Suppl 1, pp.905-916, 2012. ,
DOI : 10.3727/096368910X543376
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412085
SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion, Protein & Cell, vol.21, issue.10, pp.845-854, 2011. ,
DOI : 10.1096/fj.06-6558com
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875294
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression, British Journal of Cancer, vol.29, issue.12, pp.1901-1906, 2012. ,
DOI : 10.1016/0163-7827(90)90005-6
Mesenchymal Stem Cells Induce Resistance to Chemotherapy through the Release of Platinum-Induced Fatty Acids, Cancer Cell, vol.20, issue.3, pp.370-383, 2011. ,
DOI : 10.1016/j.ccr.2011.08.010
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, vol.9, issue.7162, pp.557-563, 2007. ,
DOI : 10.3233/BD-2007-26107
Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile, Journal of Translational Medicine, vol.12, issue.1, p.59, 2014. ,
DOI : 10.1172/JCI45273
URL : http://doi.org/10.1186/1479-5876-12-59
The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance, Clinical Cancer Research, vol.14, issue.9, pp.2519-2526, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-2223
Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours, PLoS ONE, vol.171, issue.2, p.3894, 2008. ,
DOI : 10.1371/journal.pone.0003894.s002
Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis, International Journal of Cancer, vol.16, pp.2090-2101, 2010. ,
DOI : 10.1016/S0002-9440(10)65669-6
Microenvironment mesenchymal cells protect ovarian cancer cell lines from apoptosis by inhibiting XIAP inactivation, Cell Death and Disease, vol.126, issue.10, p.887, 2013. ,
DOI : 10.1002/pmic.200700231
URL : http://doi.org/10.1038/cddis.2013.384
Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis, Cancer Res. Biochem. Biophys. Res. Commun, vol.73, issue.446, pp.5657-5668, 2013. ,
Presence of Mesenchymal Stem Cells in Human Bone Marrow After Exposure to Chemotherapy: Evidence of Resistance to Apoptosis Induction, Stem Cells, vol.27, issue.12, pp.2753-2765, 2006. ,
DOI : 10.1172/JCI0216098
Adipose-derived stem cells retain their regenerative potential after methotrexate treatment, Experimental Cell Research, vol.327, issue.2, pp.222-233, 2014. ,
DOI : 10.1016/j.yexcr.2014.06.015
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164584
Chemokine Receptors and Stromal Cells in the Homing and Homeostasis of Chronic Lymphocytic Leukemia B Cells, Leukemia & Lymphoma, vol.56, issue.3, pp.461-466, 2002. ,
DOI : 10.1002/1097-0142(19850715)56:2<328::AID-CNCR2820560221>3.0.CO;2-Q
Environment-mediated drug resistance: a major contributor to minimal residual disease, Nature Reviews Cancer, vol.112, issue.9, pp.665-674, 2009. ,
DOI : 10.1038/nrm1229
Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance, Blood, vol.114, issue.20, pp.4441-4450, 2009. ,
DOI : 10.1182/blood-2009-07-233718
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance, Molecular Cancer Therapeutics, vol.7, issue.10, pp.3169-3175, 2008. ,
DOI : 10.1158/1535-7163.MCT-08-0314
Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation, Blood, vol.103, issue.1, pp.242-251, 2004. ,
DOI : 10.1182/blood-2003-04-1048
Translational Regulation of X-Linked Inhibitor of Apoptosis Protein by Interleukin-6: A Novel Mechanism of Tumor Cell Survival, Cancer Research, vol.64, issue.4, pp.1293-1298, 2004. ,
DOI : 10.1158/0008-5472.CAN-03-2517
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone, Blood, vol.103, issue.8, pp.3148-3157, 2004. ,
DOI : 10.1182/blood-2003-06-1984
URL : https://hal.archives-ouvertes.fr/inserm-00129502
CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells, Molecular Cancer Therapeutics, vol.7, issue.1, pp.48-58, 2008. ,
DOI : 10.1158/1535-7163.MCT-07-0042
Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer, Cell Cycle, vol.1, issue.4, pp.2473-2483, 2015. ,
DOI : 10.3402/jev.v3.24783
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613597
Mesenchymal Cell Interaction with Ovarian Cancer Cells Triggers Pro-Metastatic Properties, PLoS ONE, vol.474, issue.5, p.38340, 2012. ,
DOI : 10.1371/journal.pone.0038340.s002
URL : http://doi.org/10.1371/journal.pone.0038340
Hematopoietic cells from Gadd45a- and Gadd45b-deficient mice are sensitized to genotoxic-stress-induced apoptosis, Oncogene, vol.18, issue.48, pp.7170-7179, 2005. ,
DOI : 10.1038/sj.onc.1202885
Induction of gadd45beta by NF-kappaB downregulates proapoptotic JNK signalling, Nature, vol.414, issue.6861, pp.308-313, 2001. ,
DOI : 10.1038/35104560
The Role of C/EBP-?? LIP in Multidrug Resistance, JNCI: Journal of the National Cancer Institute, vol.107, issue.5, 2015. ,
DOI : 10.1093/jnci/djv046
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers, Blood, vol.117, issue.3, pp.902-914, 2011. ,
DOI : 10.1182/blood-2010-01-262691
Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin ??-4-??-1 (VLA-4) with natalizumab can overcome this resistance, British Journal of Haematology, vol.69, issue.1, pp.53-64, 2011. ,
DOI : 10.1158/0008-5472.CAN-08-4173
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405035
RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow, Journal of Molecular Medicine, vol.117, issue.1, pp.77-92, 2014. ,
DOI : 10.1182/blood-2010-07-155663
Wnt pathway contributes to the protection by bone marrow stromal cells of acute lymphoblastic leukemia cells and is a potential therapeutic target, Cancer Letters, vol.333, issue.1, pp.9-17, 2013. ,
DOI : 10.1016/j.canlet.2012.11.056
Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-??-catenin signaling, Blood, vol.121, issue.10, pp.1824-1838, 2013. ,
DOI : 10.1182/blood-2012-02-412890
BMSC enhance the survival of paclitaxel treated squamous cell carcinoma cells in vitro, Cancer Biology & Therapy, vol.11, issue.3, pp.349-357, 2011. ,
DOI : 10.4161/cbt.11.3.14179
Le microenvironnement tumoral et la r??sistance th??rapeutique, m??decine/sciences, vol.30, issue.4, pp.445-451, 2014. ,
DOI : 10.1051/medsci/20143004021
Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1, Blood, vol.97, issue.2, pp.346-351, 2001. ,
DOI : 10.1182/blood.V97.2.346
Tipifarnib and Bortezomib Are Synergistic and Overcome Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma and Acute Myeloid Leukemia, Clinical Cancer Research, vol.12, issue.2, pp.591-599, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-1792
Overcoming cancer therapy resistance by targeting inhibitors of apoptosis proteins and nuclear factor-kappa B, Am. J. Transl. Res, vol.1, pp.1-15, 2009. ,
Targeting NF??B mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2, Cancer Biology & Therapy, vol.58, issue.7, pp.678-689, 2011. ,
DOI : 10.1158/1078-0432.CCR-06-1426
1??,25-Dihydroxyvitamin D3 inhibits cell growth and NF??B signaling in tamoxifen-resistant breast cancer cells, Steroids, vol.85, issue.85, pp.30-35, 2014. ,
DOI : 10.1016/j.steroids.2014.04.001
The NF-??B pathway blockade by the IKK inhibitor PS1145 can overcome Imatinib resistance, Leukemia, vol.12, issue.1, pp.61-67, 2006. ,
DOI : 10.1016/S0065-230X(02)85003-5
??-catenin is a target for the ubiquitin???proteasome pathway, The EMBO Journal, vol.16, issue.13, pp.3797-3804, 1997. ,
DOI : 10.1093/emboj/16.13.3797
Wnt/??-catenin pathway in bone cancers, Tumor Biology, vol.239, issue.10, pp.9439-9445, 2014. ,
DOI : 10.1016/j.intimp.2013.11.021
Can we safely target the WNT pathway?, Nature Reviews Drug Discovery, vol.31, issue.7, pp.513-532, 2014. ,
DOI : 10.1158/1078-0432.CCR-09-2943
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426976
c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia, Leukemia Research, vol.39, issue.1, pp.92-99, 2015. ,
DOI : 10.1016/j.leukres.2014.11.004
MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis, PLoS ONE, vol.327, issue.8, p.71978, 2013. ,
DOI : 10.1371/journal.pone.0071978.s006
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750050/pdf
Mesenchymal stem cells in tumor development, Cell Adhesion & Migration, vol.61, issue.3, pp.220-230, 2012. ,
DOI : 10.1126/science.1099513
The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells, EMBO reports, vol.30, issue.5, pp.412-422, 2012. ,
DOI : 10.1007/s10555-011-9280-5
Bone marrow-derived mesenchymal stem cells and the tumor microenvironment, Cancer and Metastasis Reviews, vol.15, issue.289???98, pp.249-261, 2010. ,
DOI : 10.3109/10428199809059251
ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway, International Journal of Cancer, vol.273, issue.11, pp.2598-2609, 2015. ,
DOI : 10.1074/jbc.273.9.4928
Transcriptional repression of IFN??1 by ATF2 confers melanoma resistance to therapy, Oncogene, vol.136, issue.46, 2015. ,
DOI : 10.1002/ijc.29004
ATF2 confers radiation resistance to human melanoma cells, Oncogene, vol.16, issue.4, pp.523-531, 1998. ,
DOI : 10.1038/sj.onc.1201566
Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras, Nature, vol.85, issue.7262, pp.411-414, 2009. ,
DOI : 10.1038/nature08279
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119783
Loss of B-cell translocation gene 2 expression in estrogen receptor-positive breast cancer predicts tamoxifen resistance, Cancer Science, vol.366, issue.Suppl. 2, pp.675-682, 2014. ,
DOI : 10.1056/NEJMoa1109653
Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms, Leukemia, vol.17, issue.6, pp.1175-1182, 2003. ,
DOI : 10.1038/sj.leu.2402924
Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas, Blood, vol.110, issue.5, pp.1631-1638, 2007. ,
DOI : 10.1182/blood-2006-11-060350
Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells, Journal of Experimental & Clinical Cancer Research, vol.28, issue.1, p.141, 2009. ,
DOI : 10.1186/1756-9966-28-141
URL : http://doi.org/10.1186/1756-9966-28-141
Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth, Leukemia, vol.102, issue.2, pp.304-310, 2007. ,
DOI : 10.1038/sj.leu.2404489
Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines, Blood, vol.103, issue.9, pp.3503-3510, 2004. ,
DOI : 10.1182/blood-2003-07-2340
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells, Blood, vol.118, issue.2, pp.380-389, 2011. ,
DOI : 10.1182/blood-2010-12-326694
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy, Blood Cancer Journal, vol.25, issue.5, p.73, 2012. ,
DOI : 10.1038/leu.2011.103
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias, Molecular Cancer Therapeutics, vol.5, issue.12, pp.3113-3121, 2006. ,
DOI : 10.1158/1535-7163.MCT-06-0228
Mesenchymal Stem Cells in Early Entry of Breast Cancer into Bone Marrow, PLoS ONE, vol.285, issue.6, p.2563, 2008. ,
DOI : 10.1371/journal.pone.0002563.s005
Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis, Haematologica, vol.95, issue.7, pp.1081-1089, 2010. ,
DOI : 10.3324/haematol.2009.017178
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895031
Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12, International Journal of Cancer, vol.2010, issue.3, pp.715-725, 2011. ,
DOI : 10.1111/IGC.0b013e3181b7a40e
Microenvironmental Remodeling as a Parameter and Prognostic Factor of Heterogeneous Leukemogenesis in Acute Myelogenous Leukemia, Cancer Research, vol.75, issue.11, pp.2222-2231, 2015. ,
DOI : 10.1158/0008-5472.CAN-14-3379
Cells from CML Patients Have Lower Integrin-Dependent Migration and Adhesion in Response to the Chemokine SDF-1, Stem Cells, vol.27, issue.3, pp.259-266, 2002. ,
DOI : 10.1155/1998/764986
p53 activation of mesenchymal stromal cells partially abrogates microenvironment-mediated resistance to FLT3 inhibition in AML through HIF-1??-mediated down-regulation of CXCL12, Blood, vol.118, issue.16, pp.4431-4439, 2011. ,
DOI : 10.1182/blood-2011-02-334136
Murine Bone Marrow Stromal Cells Sustain In Vivo the Survival of Hematopoietic Stem Cells and the Granulopoietic Differentiation of More Mature Progenitors, Stem Cells, vol.76, issue.10, pp.1626-1633, 2005. ,
DOI : 10.1634/stemcells.2005-0041
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization, Blood, vol.123, issue.7, pp.1032-1039, 2014. ,
DOI : 10.1182/blood-2013-03-493924
AMD3100-mediated production of interleukin-1 from mesenchymal stem cells is key to chemosensitivity of breast cancer cells, Am. J. Cancer Res, vol.1, pp.701-715, 2011. ,
Interleukin-6 as a Therapeutic Target, Clinical Cancer Research, vol.21, issue.6, pp.1248-1257, 2015. ,
DOI : 10.1158/1078-0432.CCR-14-2291
Interleukin-6 Inhibits Apoptosis of Malignant Plasma Cells, Cellular Immunology, vol.162, issue.2, pp.248-255, 1995. ,
DOI : 10.1006/cimm.1995.1076
Signal Transducers and Activators of Transcription 3 Pathway Activation in Drug-Resistant Ovarian Cancer, Clinical Cancer Research, vol.12, issue.17, pp.5055-5063, 2006. ,
DOI : 10.1158/1078-0432.CCR-06-0861
Interleukin-6-Type Cytokines Upregulate Expression of Multidrug Resistance-Associated Proteins in NHEK and Dermal Fibroblasts, Journal of Investigative Dermatology, vol.124, issue.1, pp.28-37, 2005. ,
DOI : 10.1111/j.0022-202X.2004.23499.x
??1 Integrin Adhesion Enhances IL-6-Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation, Cancer Research, vol.69, issue.3, pp.1009-1015, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-2419
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells, Cancer Letters, vol.295, issue.1, pp.110-123, 2010. ,
DOI : 10.1016/j.canlet.2010.02.019
Autocrine production of interleukin-6 confers ovarian cancer cells resistance to tamoxifen via ER isoforms and SRC-1, Molecular and Cellular Endocrinology, vol.382, issue.2, pp.791-803, 2014. ,
DOI : 10.1016/j.mce.2013.10.029
Interleukin-6 affects melphalan-induced DNA damage and repair in human multiple myeloma cells, Anticancer Res, vol.22, pp.231-234, 2002. ,
Bone marrow mesenchymal stem cells are abnormal in multiple myeloma, Leukemia, vol.63, pp.1079-1088, 2007. ,
DOI : 10.1016/S0002-9440(10)63348-2
URL : https://hal.archives-ouvertes.fr/inserm-00270565
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells, Leukemia, vol.132, issue.9, pp.1892-1900, 2007. ,
DOI : 10.1038/sj.leu.2404282
The emerging mechanisms of isoform-specific PI3K signalling, Nature Reviews Molecular Cell Biology, vol.11, issue.5, pp.329-341, 2010. ,
DOI : 10.1128/MCB.10.12.6742
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting, Nature Reviews Cancer, vol.26, issue.1, pp.7-24, 2015. ,
DOI : 10.1016/j.ccr.2014.05.020
The Role of Adipose Tissue and Obesity in Causing Treatment Resistance of Acute Lymphoblastic Leukemia, Frontiers in Pediatrics, vol.7, issue.4, p.53, 2014. ,
DOI : 10.1371/journal.pone.0033738
PPAR?? and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia, Blood, vol.122, issue.6, pp.969-980, 2013. ,
DOI : 10.1182/blood-2013-03-489468
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance, Nature, vol.9, issue.7533, pp.209-213, 2015. ,
DOI : 10.1038/nrc1697
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465385
Sphingosine Kinase/Sphingosine 1-Phosphate Signaling in Cancer Therapeutics and Drug Resistance, Handb. Exp. Pharmacol, pp.3-27978, 2013. ,
DOI : 10.1007/978-3-7091-1511-4_1
Bioactivity and Prognostic Significance of Growth Differentiation Factor GDF15 Secreted by Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma, Cancer Research, vol.72, issue.6, pp.1395-1406, 2012. ,
DOI : 10.1158/0008-5472.CAN-11-0188
Alternative Fuels for Cancer Cells, The Cancer Journal, vol.21, issue.2, pp.49-55, 2015. ,
DOI : 10.1097/PPO.0000000000000104
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4380238
Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase via Release of Glutamine, Cancer Research, vol.73, issue.10, pp.2998-3006, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-4402
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase, Journal of Clinical Investigation, vol.117, issue.4, pp.1049-1057, 2007. ,
DOI : 10.1172/JCI30235
Exosomes Derived from Mesenchymal Stem Cells, International Journal of Molecular Sciences, vol.12, issue.3 ,
DOI : 10.1371/journal.pone.0082949
Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells, PLoS ONE, vol.361, issue.12, p.84256, 2013. ,
DOI : 10.1371/journal.pone.0084256.g006
URL : http://doi.org/10.1371/journal.pone.0084256
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells, Science Signaling, vol.105, issue.30, p.63, 2014. ,
DOI : 10.1073/pnas.0804549105
Study on the bone marrow mesenchymal stem cells induced drug resistance in the U937 cells and its mechanism, Chin. Med. J. (Engl.), vol.119, pp.905-910, 2006. ,
Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins, Leukemia, vol.16, issue.9, pp.1713-1724, 2002. ,
DOI : 10.1038/sj.leu.2402608
Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells, Blood, vol.116, issue.7, pp.1083-1091, 2010. ,
DOI : 10.1182/blood-2009-10-246199
Circumvention of Mcl-1-Dependent Drug Resistance by Simultaneous Chk1 and MEK1/2 Inhibition in Human Multiple Myeloma Cells, PLoS ONE, vol.19, issue.3, p.89064, 2014. ,
DOI : 10.1371/journal.pone.0089064.s006
Guide affection de longue durée 30 'cancer de l, 1980. ,
Evaluating cell lines as tumour models by comparison of genomic profiles, Nature Communications, vol.29, p.2126, 2013. ,
DOI : 10.1038/nbt.1754
Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression, Journal of Ovarian Research, vol.7, issue.1, p.40, 2014. ,
DOI : 10.1016/j.jconrel.2011.06.031